PMCs can promote the occurrence of peritoneal fibrosis through MMT, transforming growth factor-beta (TGF-β), and hypoxia-inducible factors, which are only some of the critical pathways involved in this process. The gene discussed is TGFB1; the disease is Peritoneal Fibrosis.